Acute promyelocytic leukemia with t(15;17): Frequency of additional clonal chromosome abnormalities and FLT3 mutations

Leukemia and Lymphoma

Volumn 49, Issue 12, 2008, Pages 2387-2389

  Chauffaille, Maria de Lourdes ^a,b   Borri, Daniela ^a,b   Proto Siqueira, Rodrigo ^b   Moreira, Eloisa S ^b   Alberto, Fernando L ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CD135 ANTIGEN; DNA; RETINOIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CHILD; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; DNA DETERMINATION; FEMALE; FEVER; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INFANT; LEUKEMOGENESIS; LEUKOCYTOSIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSAL BLEEDING; MUTATION RATE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RECIPROCAL CHROMOSOME TRANSLOCATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MUTATION; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 57449101038     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802511248     Document Type: Article

References (15)

1. Wang, Z. Y. and Chen, Z. (2008) Acute promyelocytic leukemia: From highly fatal to highly curable. Blood, 111, pp. 2505-2515.
2. Douer, D. (2003) The epidemiology of acute promyelocitic leukemia. Best Pract Res Clin Haematol, 16, pp. 357-367.
3. Kelly, L. M., Kutok, J. L., Willians, I. R., Boulton, C. L., Amaral, S. M. Curley, D. P. et al. (2002) PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci USA, 99, pp. 8283-8288.
4. Gilliland, D. G. (2003) FLT3-activating mutations in acute promyelocytic leukemia: A rationale for risk-adapted therapy with FLT3 inhibitors. Best Pract Res clin Haematol, 16, pp. 409-417.
5. Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y. Miyawaki, S. et al. (2001) Activating mutation of D835Y within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, pp. 2434-2439.
6. Roldan, T MM, Ramirez, P. H., Guerchicoff, E. S., Antuña, G. M. and Santovenia, J MB (2001) Frecuencia de la leucemia promielocítica em Cuba. Rev Cubana Hematol Inmunol Hemoter, 17, pp. 49-54.
7. Jaffe, E. S., Harris, N. L., Stein, H. and Vardiman, J. W. (2001) World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon
8. Chauffaille, M. L., Figueiredo, M. S., Beltrani, R., Antunes, S. V., Yamamoto, M. and Kerbauy, J. (2001) Acute promyelocytic leukemia: The study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques. Braz J Med Biol Res, 34, pp. 735-743.
9. ISCN (2005) An International System for Human Cytogenetic Nomenclature. S. Karger, Basel
10. Nakao, M., Yokota, S., Iwai, T., Kaneko, H., Horiike, S. Kashima, K. et al. (1996) Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia, 10, pp. 1911-1918.
11. Botton, S., Chevret, S., Sanz, M., Dombret, H., Thomaz, X. Guerci, A. et al. (2000) Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: Results of APL 96 trial. Br J Haematol, 111, pp. 801-806.
12. Ribeiro, R. C. and Rego, E. Management of APL in developing countries: epidemiology, challenges abd opportunities for International Collaboration, Hematology. American Society of Hematology Education Book; Washington DC; 2006, pp. 162-168.
13. Xu, L., Zhao, W. L., Su, X. Y., Zhao, M., Wang, C. Gao, Y. R. et al. (2001) Molecular cytogenetic characterization and clinical relevance of addition, complex and/variant chromosome abnormalities in acute promyelocytic leukemia. Leukemia, 15, pp. 1359-1368.
14. Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U. Platzbecker, U. et al. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenoos leukemia: Association with FAB subtypes, and identification of subgroups with poor prognosis. Blood, 99, pp. 4326-4335.
15. Lo-Coco, F. and Ammatuna, E. (2006) The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Am Soc Hematol Washington DC, 514, pp. 156-161.